logo
logo

Docbot Closes Series A Financing Led By Khosla Ventures And Appoints Andrew J. Ritter As Ceo

Docbot Closes Series A Financing Led By Khosla Ventures And Appoints Andrew J. Ritter As Ceo

05/24/21, 12:10 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgirvine
Round Type
series a
Docbot, Inc., an artificial intelligence (AI) technology company focusing on gastrointestinal (GI) disease, announced today the closing of a Series A round. In conjunction with the financing, the company has appointed Andrew J. Ritter as CEO after he led the sale of Ritter Pharmaceuticals (NASDAQ:RTTR) in 2020. Andrew has over 16 years of experience in GI disease and earned an MBA from the Wharton School at the University of Pennsylvania.

Company Info

Company
Docbot
Location
irvine, california, united states
Additional Info
Docbot, Inc. is an artificial intelligence technology company focusing on gastrointestinal (GI) disease. Docbot’s products are built on the UltivisionAI software platform for real-time image analysis, automated reporting, and analytic tools to improve patient care and clinical workflows. UltivisionAI is an investigational device and has not received FDA clearance. For more information, visit www.docbot.ai.